Isreali hedge fund prefers 'cheap' Pfizer shares; Canadian drugstores fight generic price cuts;

@FiercePharma: Mylan chief's pay tops $16M; Cephalon's drops to $11M. Article | Follow @FiercePharma

> Researchers see cancer vaccine revolution on the horizon. Report

> Sphera Global Healthcare Fund, an Israeli hedge fund that's beaten the market since its founding in 2007, is avoiding local generics maker Teva Pharmaceutical Industries in favor of "cheap" Pfizer shares. Report

> Shoppers Drug Mart and other Canadian drugstores said price cuts to generic medications proposed by the Ontario government could lead to job cuts and store closings. Report

> The FDA is cracking down on what are billed as fat-melting injections used in spas across the U.S., saying the drugs have not been proven safe or effective. Report

> Valeant Pharmaceuticals, which has a small presence in Raleigh-Durham's Research Triangle Park, is in discussions to commit to a proposed office building in the heart of downtown Durham, N.C. Report

> Sun Pharmaceutical Industries won an FDA nod to sell a generic version of GlaxoSmithKline's antidepressant Wellbutrin SR. Report

Biotech News

 @FierceBiotech: Pfizer R&D chief touts 'golden age' of drug discovery. Article | Follow @FierceBiotech

 @JohnCFierce: $25M upfront is the beginning of a beautiful friendship. $50M upfront says you really care. $100M upfront says Pfizer's gone crazy again. | Follow @JohnCFierce

> FDA panel rejects Forest, Nycomed drug Daxas for COPD. Item

> Sagent raises $40 million, increases reach in China. Report

> Sanofi inks $335 million diabetes deal with CureDM. Article

> Fate buys Verio, grabs more stem cell tech. Story

Manufacturing News

> Baxter has resolved manufacturing issues cited in an FDA warning letter concerning clogged filters at a plant in Belgium, where it makes immune-system treatment Gammagard. Item

> FDA update IDs 'new,' lower-potency heparin. Story

> NIH unveils clinical trial supply facility; plans service expansion. Article

> REMS, FDAAA restrain annual drug-approval rate. Report

Vaccines News

> iBio tech to be used for anthrax, plague vax. Item

> Flu vaccines would probably protect children better if they included both strains of influenza B instead of just one, Saint Louis University researchers say. Article

> Council asks for halt of Gardasil program in India. Report

> Parents' vaccine fears causing measles revival. Story

And Finally... Should depression sufferers deprive themselves of sleep and do Transcendental Meditation instead? Report | Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.